Paramjeet Randhawa Purchases 3,050 Shares of Hercules Capital (NYSE:HTGC) Stock

March 6, 2026 by InsiderTrades.com

Key Points

Director Paramjeet Randhawa bought 3,050 shares on March 4 at an average price of $14.78 for $45,079, increasing his stake to 19,560 shares (an ~18.47% rise), as disclosed in an SEC filing.
Hercules cut its quarterly dividend to $0.07 (paid March 4), equal to $0.28 annually and a 1.9% yield, with a payout ratio of 87.43%.
Recent quarter: EPS of $0.48 met estimates but revenue missed ($133.25M vs. $141.57M expected); shares traded near $14.92 (down ~1.3%), and analysts hold a consensus "Moderate Buy" with an average price target of $19.29.

Hercules Capital, Inc. (NYSE:HTGC - Get Free Report) Director Paramjeet Randhawa bought 3,050 shares of the firm's stock in a transaction that occurred on Wednesday, March 4th. The stock was purchased at an average cost of $14.78 per share, for a total transaction of $45,079.00. Following the completion of the purchase, the director owned 19,560 shares of the company's stock, valued at $289,096.80. This trade represents a 18.47% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Hercules Capital Trading Down 1.3%

HTGC traded down $0.19 during trading on Friday, hitting $14.92. 1,209,466 shares of the stock traded hands, compared to its average volume of 2,787,860. The firm has a market capitalization of $2.74 billion, a P/E ratio of 8.15 and a beta of 0.87. Hercules Capital, Inc. has a 12-month low of $13.77 and a 12-month high of $19.67. The company has a debt-to-equity ratio of 1.03, a current ratio of 1.48 and a quick ratio of 1.48. The firm has a 50-day moving average of $17.34 and a 200 day moving average of $18.05.

Hercules Capital (NYSE:HTGC - Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.48 EPS for the quarter, meeting the consensus estimate of $0.48. Hercules Capital had a net margin of 63.80% and a return on equity of 15.97%. The firm had revenue of $133.25 million during the quarter, compared to the consensus estimate of $141.57 million. During the same period in the prior year, the firm posted $0.49 earnings per share. Equities research analysts anticipate that Hercules Capital, Inc. will post 1.96 EPS for the current year.

Hercules Capital Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 4th. Stockholders of record on Wednesday, February 25th were paid a dividend of $0.07 per share. The ex-dividend date of this dividend was Wednesday, February 25th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.9%. Hercules Capital's payout ratio is presently 87.43%.

Analysts Set New Price Targets

HTGC has been the topic of a number of recent research reports. Wall Street Zen downgraded shares of Hercules Capital from a "buy" rating to a "hold" rating in a research report on Saturday, December 20th. Piper Sandler cut shares of Hercules Capital from an "overweight" rating to a "neutral" rating and decreased their target price for the stock from $20.50 to $17.50 in a report on Friday, February 13th. Lucid Cap Mkts upgraded shares of Hercules Capital to a "strong-buy" rating in a report on Monday, December 15th. Wells Fargo & Company decreased their price objective on shares of Hercules Capital from $18.00 to $17.00 and set an "overweight" rating for the company in a report on Friday, February 13th. Finally, Capital One Financial set a $19.75 target price on Hercules Capital in a report on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, Hercules Capital currently has a consensus rating of "Moderate Buy" and an average price target of $19.29.

View Our Latest Stock Analysis on Hercules Capital

Hedge Funds Weigh In On Hercules Capital

Institutional investors and hedge funds have recently modified their holdings of the company. CWM LLC increased its position in Hercules Capital by 79.6% during the second quarter. CWM LLC now owns 1,381 shares of the financial services provider's stock valued at $25,000 after acquiring an additional 612 shares during the last quarter. Fox Run Management L.L.C. grew its stake in shares of Hercules Capital by 2.8% during the 4th quarter. Fox Run Management L.L.C. now owns 24,354 shares of the financial services provider's stock valued at $458,000 after purchasing an additional 657 shares during the period. Centaurus Financial Inc. increased its position in shares of Hercules Capital by 1.8% during the 3rd quarter. Centaurus Financial Inc. now owns 37,819 shares of the financial services provider's stock valued at $715,000 after purchasing an additional 675 shares during the last quarter. Allworth Financial LP lifted its stake in shares of Hercules Capital by 11.4% in the 3rd quarter. Allworth Financial LP now owns 6,652 shares of the financial services provider's stock worth $126,000 after purchasing an additional 680 shares during the period. Finally, Rockefeller Capital Management L.P. boosted its holdings in shares of Hercules Capital by 0.5% in the second quarter. Rockefeller Capital Management L.P. now owns 143,346 shares of the financial services provider's stock worth $2,620,000 after buying an additional 697 shares during the last quarter. 19.69% of the stock is currently owned by hedge funds and other institutional investors.

About Hercules Capital

(Get Free Report)

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company's investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.